by Kevin McNerney, MD
Kevin McNerney, MD, is the first author of the article “Management practices of CAR T-cell-related inflammatory toxicities: a survey of pediatric CAR T-cell providers.” He shares in...
by ASTCT Press Release
Chicago – Feb. 16, 2026 – The American Society for Transplantation and Cellular Therapy® (ASTCT®) is pleased to announce Margaret MacMillan, MD, MSc, FRCPC, as the...
by ASTCT Press Release
The American Society for Transplantation and Cellular Therapy® (ASTCT®) presents top awards to leaders and organizations in the field of transplantation and cellular therapy at the Tandem...
by ASTCT Advocacy Update
Congress Progress in FY2026 Funding Stalled
by Zainab Shahid, MD
ASTCT’s Transplant Infectious Disease (ID) Special Interest Group (SIG) has curated a track of sessions at this year’s Tandem Meetings. Sessions center around the latest in protecting...
by David Porter
In his last message as ASTCT President, David Porter, MD, highlights how his successes in 2025 were a shared effort, made possible by the ASTCT Board, staff, and members. He reflects on key...